Nalbuphine suppresses breast cancer stem-like properties and epithelial-mesenchymal transition via the AKT-NFκB signaling pathway
Abstract Background Cancer pain is a debilitating disorder of human breast cancer and a primary determinant of the poor quality of life, and relieving pain is fundamental strategy in the cancer treatment. However, opioid analgesics, like morphine and fentanyl, which are widely used in cancer pain tr...
Main Authors: | Jiachuan Yu, Yuanyuan Luo, Qingping Wen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-05-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13046-019-1184-1 |
Similar Items
-
Nalbuphine alleviates inflammation by down-regulating NF-κB in an acute inflammatory visceral pain rat model
by: Dijiao Ruan, et al.
Published: (2022-06-01) -
SOS1 promotes epithelial-mesenchymal transition of Epithelial Ovarian Cancer(EOC) cells through AKT independent NF-κB signaling pathway
by: Min Cheng, et al.
Published: (2021-09-01) -
Submicroscopic changes in the structural components of thymus under the action of nalbuphine on the body
by: T. V. Harapko, et al.
Published: (2017-12-01) -
(20S)G-Rh2 Inhibits NF-κB Regulated Epithelial-Mesenchymal Transition by Targeting Annexin A2
by: Yu-Shi Wang, et al.
Published: (2020-03-01) -
Down-regulation of NF-κB signaling pathway promotes epithelialization of human amniotic mesenchymal stem cells
by: LIU Nizhou, et al.
Published: (2023-08-01)